Synaffix’s glycan-based antibody–drug conjugate technology is experiencing strong demand, based on its potential to improve safety and efficacy of cancer therapies without genetic engineering.

Taking Control of Vasomotor Symptoms in Breast Cancer Dr Michelle Melisko discusses why hot flashes in breast cancer are more than ‘just a side effect’ and how managing them can keep patients on life ...

Jennifer Simonson is a business journalist with a decade of experience covering entrepreneurship and small business. Drawing on her background as a founder of multiple startups, she writes for Forbes ...

SHAREit is a popular application that allows you to easily transfer photos, videos, and files between iPhone, Android, and a Windows PC or Mac without an Internet connection. 2] Using Hotspot. The ...

If you don't use your credit card, your issuer may consider your account inactive and close it. However, a closed credit card account can negatively impact your credit score, by increasing your credit ...

ASCO 2026 What ASCO 2026 Taught Us About Scaling AI in Cancer Care The next era of oncology AI won’t be won by the best model, the highest benchmarks, or flashiest press release. It will be won by the ...